Biotech News

Iridex Reports First Quarter 2026 Financial Results

IRIDEX (IRIX)IRIDEXEarnings

2026 Guidance Affirmed MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today

Related news

IRIDEX

Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...

Recent company news

Stock data

Close
0.65 USD
Market cap
20.37M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States